LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 11 of 166
Next
>>
>
251 to 275 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	OSI-027	3.33	uM	LJP6	72	hr	1334	2279	3925	0.5809	0.4102
BT-20	OSI-027	10	uM	LJP6	72	hr	1334	1653	3925	0.4212	0.1472
BT-20	WYE-125132	0.12	uM	LJP6	72	hr	1334	2175	3925	0.5540	0.3678
BT-20	WYE-125132	0.37	uM	LJP6	72	hr	1334	1913	3925	0.4875	0.2603
BT-20	Seliciclib	0.04	uM	LJP5	72	hr	1334	4094	4033	1.0156	1.0199
BT-20	Seliciclib	0.12	uM	LJP5	72	hr	1334	4007	4033	0.9941	0.9928
BT-20	Seliciclib	1.11	uM	LJP5	72	hr	1334	3827	4033	0.9489	0.9352
BT-20	Seliciclib	3.33	uM	LJP5	72	hr	1334	3442	4033	0.8529	0.8091
BT-20	AT-7519	0.12	uM	LJP6	72	hr	1334	3834	3925	0.9770	0.9701
BT-20	AT-7519	0.37	uM	LJP6	72	hr	1334	3020	3925	0.7695	0.6901
BT-20	AT-7519	3.33	uM	LJP6	72	hr	1334	350	3925	0.0894	-0.5784
BT-20	AT-7519	10	uM	LJP6	72	hr	1334	285	3925	0.0728	-0.6302
BT-20	AZD7762	1.11	uM	LJP6	72	hr	1334	2258	3925	0.5752	0.4018
BT-20	AZD7762	3.33	uM	LJP6	72	hr	1334	1438	3925	0.3665	0.0491
BT-20	AZD8055	0.04	uM	LJP6	72	hr	1334	2367	3925	0.6035	0.4440
BT-20	AZD8055	0.12	uM	LJP6	72	hr	1334	1948	3925	0.4964	0.2749
BT-20	AZD8055	3.33	uM	LJP6	72	hr	1334	1391	3925	0.3546	0.0263
BT-20	AZD8055	10	uM	LJP6	72	hr	1334	1052	3925	0.2681	-0.1421
BT-20	Sorafenib	0.12	uM	LJP6	72	hr	1334	3764	3925	0.9591	0.9471
BT-20	Sorafenib	0.37	uM	LJP6	72	hr	1334	3601	3925	0.9175	0.8923
BT-20	CP466722	0.12	uM	LJP5	72	hr	1334	4171	4033	1.0341	1.0421
BT-20	CP466722	0.37	uM	LJP5	72	hr	1334	4028	4033	0.9991	0.9992
BT-20	CP466722	3.33	uM	LJP5	72	hr	1334	4026	4033	0.9990	0.9991
BT-20	Barasertib	3.33	uM	LJP5	72	hr	1334	1239	4033	0.3069	-0.0469
BT-20	Barasertib	1.11	uM	LJP5	72	hr	1334	1544	4033	0.3827	0.0949

|<
<<
Previous
Page 11 of 166
Next
>>
>
251 to 275 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)